Test: SARS-CoV-2 IgG Elisa
SARS-CoV-2 IgG Elisa
Plasma/Serum 1.0 mL
Plasma/Serum 0.5 mL
SARS-CoV-2 IgG antibody is generated as part of the adaptive human immune response to the virus and supports a current or past infection with the COVID-19 virus. IgG antibodies to SARS-CoV-2 generally do not begin to appear until 7-10 days after infection.
Sample InstructionsCoppe Laboratories supports the Clinical Trial industry by offering COVID-19 rRTPCR and Serological Testing for screening prospective subjects and testing during the check-in process. Please contact us for more information.
1. Collect whole blood in EDTA tube labeled with patient name, date of birth, and date and time of draw. If submitting plasma, process to plasma, and place in sterile vial or cryotube labeled with patient name, date of birth, and date and time of draw. Serum should be placed in sterile vial or cryotube labeled as above.
2. Place tube into a biohazard bag with an absorbent pad and seal.
3. Complete the test request form by clicking on the green Hospital/Institution Ordering button located in the blue box. Place the form and the sample in another sealable bag or pouch, seal, and ship according to the listed shipping specifications.
4. Send the sample using an overnight delivery service. Coppe Laboratories accepts shipments MONDAY THROUGH FRIDAY. Holiday closures will be posted on the home page of the Coppe website, www.coppelabs.com.
Volume / Collection Type
N/AWB, 3.0 mL;
Plasma/Serum 1.0 mLWB, 1.0 mL;
Plasma/Serum 0.5 mLWB, Room temperature <48 hours; Plasma/Serum, Refrigerator, 6 days; frozen 1 yearWB, Room temperature; Plasma/Serum: If frozen, dry ice; if not previously frozen, ice packs
Specimen:N/AVolume / Collection Type:WB, 3.0 mL;
Plasma/Serum 1.0 mLMinimum:WB, 1.0 mL;
Plasma/Serum 0.5 mLStorage:WB, Room temperature <48 hours; Plasma/Serum, Refrigerator, 6 days; frozen 1 yearShipping:WB, Room temperature; Plasma/Serum: If frozen, dry ice; if not previously frozen, ice packs
Turn Around Time10 business days
The enzyme immunoassay (EIA) test provides a sensitive and specific, semi-quantitative assay for the detection of IgG antibodies to SARS-CoV-2. Highly specific viral protein is used to detect the antibodies to SARS-CoV-2 and limit cross-reaction with other similar viruses.